Cal-Maine Foods, Inc. (CALM)
NASDAQConsumer StaplesAgricultural Farm ProductsSnapshot 2026-09-14
$75.02+1.41%
Close 2026-09-14 · 1-day change
NASDAQConsumer StaplesAgricultural Farm ProductsSnapshot 2026-09-14
Research Workspace
Put CALM beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Packaged Foods & Meats is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — EPS near $25 in fiscal 2026: EPS -0.8 vs 24.95 target.
View ThesisManagement screens strong on capital allocation, the balance sheet.
View ManagementExpectations look high — what the market is pricing in runs ahead of what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskCALM's growth depends on stabilizing egg prices and improving execution quality. Recent earnings showed a significant decline, with EPS at -0.76 against a target of $25. The stock trades at 11× P/E, below the peer median of 12×, indicating that the market prices in more growth than expected. If CALM cuts guidance on the next call, it could lead to a further decline. Peer multiples imply a price about 13% below where it trades (it looks expensive on this basis). This read is provisional.
Trailing returns as of 2026-09-14. CALM is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 5 analysts currently covering CALM (as of Sep 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare CALM with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CALM Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Packaged Foods & Meats — fair value, gap to price, and forward P/E.
Compare the value case
Put CALM next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Earnings miss due to egg price slump threatens growth objectives.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-14. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Resolve DOJ investigation and maintain compliance
Settlement impacts compliance and regulatory standing.
Threatens: Resolve DOJ investigation and maintain compliance
DOJ investigation could impact compliance and reputation.
Settlement may impact regulatory compliance and operational costs.
Threatens: Resolve DOJ investigation and maintain compliance
DOJ investigation resolution impacted by price-fixing settlement.
Threatens: Resolve DOJ investigation and maintain compliance
Investigation may affect compliance and regulatory standing.
Advances: Pursue disciplined, accretive M&A
Settlement supports disciplined M&A strategy.
Settlement could improve market conditions and operational stability.